Content generated by AI editorial engine. Editorially supervised by Sedat ANAK.
Exxon Mobil Corporation
XOM - NYSE - $152.94 ▼ -%1.23
-
Earnings
Fri 30 Oct
Exxon opens the
books on Friday evening.
8 analysts' median target is $171[FMP target], stock is $153, +11.5% vs the analyst consensus median. After Q1 +-4.3% EPS beat[FMP earnings], the stock moved -0.2%.
↓
summary below
Quick Take - in 40 seconds
B+
HOLD
Council 3/6
-
Moonshot 54
B+ = MoonshotScore 54[multi-pillar formula] + Council 3/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].
Quick AnswerExxon Mobil Corporation (XOM)
Q1 consensus: revenue $96.2B[FMP est], EPS $3.50[FMP est]. 0 consecutive quarters of beat[FMP earnings].
$3.50
EPS Estimate
Last year $1.16 - +86% YoY YoY
-
Upstream Guidance
Previous quarter was 8%
0
Beat Streak
Expectations beaten consecutively for the last 0 quarters
Q1 EPS +-4.3% beat[FMP] but the stock -0.2% D+1[FMP D+1].
1.8 million
Investor Focus
Permian Production Growth Technology
permian_production_growth_technology
ExxonMobil remains on track to grow full-year Permian production to 1.8 million oil equivalent barrels in 2026, driven by scale, proprietary technologies, and a focus on capital efficiency and recovery.
"In the Permian, we continue to show how scale and proprietary technologies improve efficiency, recovery and long-term value creation. We remain on track to grow full year Permian production to 1.8 million oil equivalent barrels in 2026, with that growth grounded in value, not volume."
- Darren Woods, Chairman and Chief Executive Officer - Q1 FY26 Earnings Call - May 1, 2026
Upstream Production Growth Adjusted
upstream_production_growth_adjusted
Excluding external impacts like the Middle East conflict and winter storms, ExxonMobil's year-over-year upstream production increased by 8%, highlighting the benefit of its global diverse portfolio.
"But if you exclude all those external impacts, it really highlights the benefit and the value of having a global diverse portfolio. If we take those impacts out, year-over-year, our upstream production was up 8%."
- Neil Hansen, Senior Vice President and Chief Financial Officer - Q1 FY26 Earnings Call - May 1, 2026
Beaumont Refinery Payback
beaumont_refinery_payback
The Beaumont refinery expansion, completed in 2023, fully recovered its initial investment ahead of expectation, demonstrating the company's ability to generate durable returns from disciplined investments.
"The Beaumont refinery expansion, completed in 2023, fully recovered its initial investment ahead of expectation and is contributing to stronger margins and cash flow. This underscores how disciplined investments grounded in long-term market fundamentals, rigorously executed, generate durable returns independent of price cycles."
- Darren Woods, Chairman and Chief Executive Officer - Q1 FY26 Earnings Call - May 1, 2026
Guyana Record Production
guyana_record_production
Guyana continues to set a high standard for execution and development pace, achieving record production levels and exceeding initial investment bases for projects.
"Elsewhere in the Upstream, Guyana continues to set the standard for execution, development pace and value creation. We delivered record production, continued strong reliability and have Uaru, Whiptail and Hammerhead projects under construction with Uaru expecting first oil late this year."
- Darren Woods, Chairman and Chief Executive Officer - Q1 FY26 Earnings Call - May 1, 2026
Middle East Conflict Market Impact
middle_east_conflict_market_impact
The market has not yet fully felt the impact of the unprecedented disruption in oil and natural gas supply due to the Middle East conflict, with higher prices anticipated as inventories deplete and a risk premium potentially emerging.
"I think it's obvious to most that if you look at the unprecedented disruption in the world's supply of oil and natural gas, the market hasn't seen the full impact of that yet. ... So there's more to come if the Strait remains closed."
- Darren Woods, Chairman and Chief Executive Officer - Q1 FY26 Earnings Call - May 1, 2026
Stock Expert AI - Methodology
Do our scoring pillars, 7 perspectives, and Munger lens point in the same direction?
MoonshotScore
54 / 100
multi-pillar methodology. Revenue Growth and Cash Runway strong. Gross Margin weak.
How is it calculated? ->
Revenue Growth10.0
Q2 vs Q3: fast growth (+37.4%)
Gross Margin2.0
Q2: low margin (22.4%, capital-intensive or commodity)
Operating Leverage2.0
op margin healthy (15.9%)
Cash Runway10.0
FCF very strong ($17.0B, 2.6x CapEx)
R&D Intensity3.0
low R&D investment (0.0%, weak innovation)
Price Momentum7.0
RSI 55.2 positive momentum, 50d above
News Sentiment4.0
mixed (40% buy)
Council Score
3 / 6 Bullish
6 investor frameworks. 3 bullish (Ray Dalio, Ken Griffin, Buffett), 0 bearish (none), 3 neutral (Jim Simons, Klarman, Munger).
How is it calculated? ->
Ray Dalio macro - target upside +11.5%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 55
Klarman value - target upside +11.5%
Buffett quality - ROE score 4/5
Munger valuation - target upside +11.5%
Munger's Mindset character & balance sheet lens
Fairly Valued
Quality business, trading at fair value.
How is it calculated? ->
Interest CoverageAdequate
Technical Levels - Pre-earnings positioning
What levels is the stock being tested at?
RSI(14)
55.2
RSI 55.2 positive momentum, 50d above
MACD
+4.40
price above 50d - support positive
50d MA
$146
stock 4.4% above - short-term support
200d MA
$140
stock 9.1% above - long-term support
Volume (10d)
+28%
increase - pre-earnings positioning
Resistance
$171
Analyst median target - upgrade trigger if broken
Current
$153
Pre-earnings position
Support
$119
Invalidation - close below this is a technical breakdown
Pattern
Range
$119-$171 band - earnings breakout/breakdown trigger
Past Performance
Exxon's last 8 quarters: 0 consecutive beats.
BEAT
Q3 FY25
$1.88 vs $1.82 est - -0.5%
BEAT
Q4 FY25
$1.71 vs $1.70 est - -2.1%
BEAT
Q1 FY26
$1.16 vs $0.98 est - +0.6%
MISS
Q2 FY26
$3.52 vs $3.68 est - -0.2%
Q1 (May 1, 2026): EPS $3.52 vs $3.68 est[FMP], +-4.3% beat. D+1 movement: -0.2%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.
Three scenarios: what could happen?
EPS < $3.40 (no guidance)
Q1: EPS $3.52 vs $3.68 beat[FMP], stock -0.2% D+1[FMP]. Neil Hansen Q1 transcript: "If we take those impacts out, year-over-year, our upstream production was up 8%."[Neil Hansen].
"If we take those impacts out, year-over-year, our upstream production was up 8%."
- Neil Hansen, CFO - Q1 FY26 Earnings Call - May 1, 2026
Backlog concentration
No RPO/backlog concentration disclosed in Q1 earnings call.
Insider trading signal
Form 4 data is marked in the table - this page does not generate assumptions for this stock.
Our FMP plan does not provide Form 4 insider feed for this stock. This page does not generate assumptions - SEC EDGAR Form 4 can be monitored directly.
CapEx shock
Q1 CapEx $6.5B[FMP cashflow]. Q1 op margin 15.9%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.
"-"
- Neil Hansen, CFO - Q1 FY26 Earnings Call - May 1, 2026
Framework - Position discipline
After the data arrives: 3 scenarios, 3 windows
Not advice - a structural framework for earnings night. Decision discipline is yours.
Scenario A - Beat
Q1 EPS > $3.50 + CapEx discipline
Threshold: EPS > $3.50[FMP est].
Target: Break above median target $171[FMP target]; high target $184[FMP] upper bound.
Scenario B - In-Line
EPS approx $3.50 + CapEx < $6.5B
Threshold: EPS approx $3.50[FMP est], Q1 CapEx < $6.5B[FMP].
Target: Consolidation in the band between current $153[FMP] and median $171[FMP].
Scenario C - Miss
EPS < $3.40 or CapEx >= $6.5B
Threshold: EPS < $3.40[FMP estx0.97].
Target: Current $153 below SMA200 $140[FMP], if rejection continues, $119[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.
Market Outlook
What do 8 analysts say?
Wall Street Consensus
$171
12-month median target price (+11.5% gap to the analyst consensus median)
Risk Management
$119
Invalidation level - critical support threshold
$146 - 50-day MA (above, +4.4%)
$140 - 200-day MA (above, +9.1%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - XOM Q1 FY27
B+
You read it in 5 minutes. When the numbers come out on Friday evening - you know what you're looking at.
Data arrives at night. The framework is ready now.
Data arrives on Friday evening. The framework is ready on this page: Q1 EPS threshold $3.50[FMP], CapEx threshold "below $6.5B". Two anchors, three scenarios.
Comparison
Stock Expert AI is free today — no credit card.
3 subscriptions. 1 platform.
Seeking Alpha $299/yr - analyst opinions + earnings coverage
TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades
Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts
Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing
Stock Expert AI is free today — no credit card. Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.
Educational tool, not investment advice. Past performance does not guarantee future results.
Calendar
Catalyst Calendar - 90-day forward look
Oct 30, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Oct 31, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Dec 14, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Jan 30, 2027EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)
DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.
Frequently Asked Questions
What does the XOM earnings preview cover?
This Exxon Mobil Corporation (XOM) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.
What should investors watch for in XOM earnings?
Exxon Mobil Corporation (XOM): Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.
Where do the numbers on this page come from?
Exxon Mobil Corporation (XOM): Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.
Is this a buy or sell recommendation?
Exxon Mobil Corporation (XOM): No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.